Julia Aijun Wang - Jun 30, 2021 Form 3 Insider Report for BeiGene, Ltd. (BGNE)

Role
Chief Financial Officer
Signature
/s/ Qing Nian, as Attorney-in-Fact
Stock symbol
BGNE
Transactions as of
Jun 30, 2021
Transactions value $
$0
Form type
3
Date filed
7/1/2021, 04:55 PM
Next filing
Jul 1, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BGNE Ordinary Shares 83.9K Jun 30, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BGNE Share Option (Right to Buy) Jun 30, 2021 Ordinary Shares 105K $14.66 Direct F2
holding BGNE Share Option (Right to Buy) Jun 30, 2021 Ordinary Shares 178K $26.53 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying unvested restricted share units.
F2 These securities vest over a four-year period as follows: 25% on June 30, 2021 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
F3 These securities vest over a four-year period as follows: 25% on June 16, 2022 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney